You have free access to this content

Cancer

Cover image for Cancer

15 September 2003

Volume 98, Issue 6

Pages 1105–1329

  1. Review Articles

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. You have free access to this content
      Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia (pages 1105–1113)

      Jorge Cortes, Moshe Talpaz, Susan O'Brien, Francis Giles, Mary Beth Rios, Jianquin Shan, Stefan Faderl, Guillermo Garcia-Manero, Alessandra Ferrajoli, William Wierda and Hagop Kantarjian

      Version of Record online: 31 JUL 2003 | DOI: 10.1002/cncr.11629

      • original image
      • original image
      • original image
      • original image
      • original image

      The poor prognostic relevance of older age in patients with chronic myelogenous leukemia appeared to be minimized significantly with the availability of imatinib, an effective Bcr-Abl-targeted therapy that is delivered orally with minimal side effects.

  2. Original Article

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Disease Site

      Breast Disease
      You have free access to this content
      Treatment of postmastectomy lymphedema with low-level laser therapy : A double blind, placebo-controlled trial (pages 1114–1122)

      Colin J. Carati, Sandy N. Anderson, Bren J. Gannon and Neil B. Piller

      Version of Record online: 1 AUG 2003 | DOI: 10.1002/cncr.11641

      • original image
      • original image
      • original image

      The current study describes the results of a double blind, placebo-controlled, randomized, single crossover trial of the treatment of patients with postmastectomy lymphedema, using low-level laser therapy. Two cycles of laser treatment were found to significantly reduce affected limb volume, extracellular fluid, and tissue hardness in approximately 33% of participants 3 months after treatment. This result was significantly better than that achieved with one cycle of treatment, which was found to be no better than placebo.

    2. You have free access to this content
      ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2 : Poor responsiveness to chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil is associated with ErbB2 overexpression and with p21Cip1 overexpression (pages 1123–1130)

      Wentao Yang, Kristine S. Klos, Xiaoyan Zhou, Jun Yao, Ying Yang, Terry L. Smith, Daren Shi and Dihua Yu

      Version of Record online: 31 JUL 2003 | DOI: 10.1002/cncr.11625

      • original image
      • original image
      • original image

      The authors report that p21Cip1 expression was correlated with ErbB2 overexpression in samples from patients with breast carcinoma and that both p21Cip1 expression and ErbB2 expression were correlated with a worse disease-free survival (DFS) in patients with breast carcinoma who were treated with a regimen of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) compared with patients who had breast carcinoma with no p21Cip1 expression or with low ErbB2 expression. p34Cdc2-Tyr15 phosphorylation also was correlated with ErbB2 overexpression but was not correlated with a worse DFS in CMF-treated patients.

    3. You have free access to this content
      Childbearing and survival after breast carcinoma in young women (pages 1131–1140)

      Beth A. Mueller, Michael S. Simon, Dennis Deapen, Aruna Kamineni, Kathleen E. Malone and Janet R. Daling

      Version of Record online: 11 AUG 2003 | DOI: 10.1002/cncr.11634

      When compared with age-matched, race-matched, diagnosis year-matched, and stage-matched young patients with breast carcinoma without births occurring after diagnosis, women with births occurring 10 months or more after diagnosis had a decreased risk of dying. Women pregnant at the time of diagnosis had a similar mortality. The results of this multicenter, population-based study support observational studies that suggested that subsequent childbearing is unlikely to increase the risk of mortality among young women with breast carcinoma.

  3. Original Articles

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Disease Site

      Breast Disease
      You have free access to this content
      Older women with breast carcinoma are less likely to receive adjuvant chemotherapy : Evidence of possible age bias? (pages 1141–1149)

      Stacy Woodard, Padma C. Nadella, Linda Kotur, John Wilson, William E. Burak and Charles L. Shapiro

      Version of Record online: 11 AUG 2003 | DOI: 10.1002/cncr.11640

      The authors initially hypothesized that the disparity in adjuvant chemotherapy use between older and younger patients with breast carcinoma would become less significant after adjustments were made for confounders and effect modifiers. However, the current retrospective analysis revealed that after controlling for confounders and effect modifiers, women ages 50–65 years and women age > 65 years with estrogen receptor (ER)-positive breast carcinoma were approximately 6 and 62 times less likely, respectively, than women age < 50 years with ER-positive breast carcinoma to receive adjuvant chemotherapy. In addition, among women with ER-negative breast carcinoma, women age > 65 years were found to be roughly 7 times less likely than women age < 50 years to receive adjuvant chemotherapy.

    2. You have free access to this content
      Neoadjuvant chemotherapy for breast carcinoma : Multidisciplinary considerations of benefits and risks (pages 1150–1160)

      Thomas A. Buchholz, Kelly K. Hunt, Gary J. Whitman, Aysegul A. Sahin and Gabriel N. Hortobagyi

      Version of Record online: 17 JUL 2003 | DOI: 10.1002/cncr.11603

      • original image
      • original image
      • original image

      Neoadjuvant chemotherapy offers a number of advantages for patients with breast carcinoma, including the possibility of breast conservation therapy for patients with large primary breast tumors. However, treatment sequencing with chemotherapy raises a number of important issues for medical oncologists, surgeons, radiation oncologists, pathologists, and radiologists. Therefore, a multidisciplinary team should be involved to optimally coordinate this treatment approach.

    3. Gastrointestinal Tract
      You have free access to this content
      The effect of a low-fat, high fiber, fruit and vegetable intervention on rectal mucosal proliferation (pages 1161–1168)

      Ruth Pfeiffer, Lisa McShane, Michael Wargovich, Randall Burt, Walter Kikendall, Michael Lawson, Elaine Lanza and Arthur Schatzkin

      Version of Record online: 16 JUL 2003 | DOI: 10.1002/cncr.11608

      The authors assessed the effects of a 4-year, low-fat, high-fiber, fruit and vegetable-enriched dietary intervention on colorectal epithelial cell proliferation among 399 participants from the Polyp Prevention Trial, a randomized, multicenter trial with adenoma recurrence as the primary endpoint. There were no significant differences between the changes of two summary measures of proliferation, labeling index and proliferative height, over the 4-year period for the intervention group and the control group. Thus, the dietary intervention did not alter rectal mucosal cell proliferation rates.

  4. Original Article

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Disease Site

      Genitourinary Disease
      You have free access to this content
      Prostate carcinoma presentation, diagnosis, and staging : An update from the National Cancer Data Base (pages 1169–1178)

      David C. Miller, Khaled S. Hafez, Andrew Stewart, James E. Montie and John T. Wei

      Version of Record online: 31 JUL 2003 | DOI: 10.1002/cncr.11635

      The authors observed that a high proportion of tumors are detected in asymptomatic men, suggesting widespread implementation of prostate carcinoma screening in the community. Compared with symptomatic patients, prostate carcinomas in asymptomatic men was associated with lower pretreatment prostate specific antigen levels, tumor stage, and grade. Selective use of staging evaluations, based on risk of metastatic disease, was relatively uncommon in 1998. The observations reported in the current study provided a national point of reference for evaluating current methods of prostate carcinoma diagnosis and staging.

  5. Original Articles

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Disease Site

      Head and Neck Disease
      You have free access to this content
      Craniofacial surgery for malignant skull base tumors : Report of an International Collaborative Study (pages 1179–1187)

      Snehal G. Patel, Bhuvanesh Singh, Ashok Polluri, Patrick G. Bridger, Giulio Cantu, Anthony D. Cheesman, Geraldo M. deSa, Paul Donald, Dan Fliss, Patrick Gullane, Ivo Janecka, Shin-etsu Kamata, Luiz P. Kowalski, Dennis H. Kraus, Paul A. Levine, Luiz R. M. dos Santos, Sultan Pradhan, Victor Schramm, Carl Snyderman, William I. Wei and Jatin P. Shah

      Version of Record online: 8 AUG 2003 | DOI: 10.1002/cncr.11630

      • original image

      The current large multiinstitutional study demonstrated the safety and efficacy of craniofacial surgery for patients with malignant tumors of the skull base. The histology of the primary tumor, its intracranial extent, and the status of surgical margins were independent determinants of outcome.

    2. Hematologic Oncology
      You have free access to this content
      Non-Hodgkin lymphoma in elderly patients : Experience at Taipei Veterans General Hospital (pages 1188–1195)

      Li-Yuan Bai, Muh-Hwa Yang, Tzeon-Jye Chiou, Jin-Hwang Liu, Chueh-Chuan Yen, Wei-Shu Wang, Liang-Tsai Hsiao, Ta-Chung Chao and Po-Min Chen

      Version of Record online: 17 JUL 2003 | DOI: 10.1002/cncr.11609

      • original image
      • original image
      • original image

      The selection of treatment regimens for elderly patients with non-Hodgkin lymphoma remains an inexact process. An anthracycline-containing regimen may be especially beneficial for patients in the high-intermediate-risk group (as determined by International Prognostic Index score).

    3. Hematologic Malignancies
      You have free access to this content
      Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus–associated Burkitt lymphoma (pages 1196–1205)

      Eunice S. Wang, David J. Straus, Julie Teruya-Feldstein, Jing Qin, Carol Portlock, Craig Moskowitz, Andre Goy, Eric Hedrick, Andrew D. Zelenetz and Ariela Noy

      Version of Record online: 1 AUG 2003 | DOI: 10.1002/cncr.11628

      • original image
      • original image

      The results of the current nonrandomized retrospective study suggest that intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) is feasible and well tolerated in human immunodeficiency virus (HIV)-positive adults with Burkitt lymphoma (BL). CODOX-M/IVAC may be appropriate in all adult patients with BL, especially those with poor prognostic factors, regardless of HIV status.

    4. You have free access to this content
      Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia : Correlation with molecular subtypes of PML/RARα and clinical features (pages 1206–1216)

      Lee-Yung Shih, Ming-Chung Kuo, Der-Cherng Liang, Chein-Fuang Huang, Tung-Liang Lin, Jin-Hou Wu, Po-Nan Wang, Po Dunn and Chang-Liang Lai

      Version of Record online: 20 AUG 2003 | DOI: 10.1002/cncr.11636

      • original image
      • original image
      • original image
      • original image
      • original image

      The current study examined internal tandem duplication (ITD) and Asp835 mutations of the fms-like tyrosine kinase 3 (FLT3) gene in a large population of patients with acute promyelocytic leukemia (APL) and analyzed these mutations for potential correlations with clinicohematologic features and outcome. The analysis demonstrated that FLT3/ITD frequently was associated with S-type PML/RARα. Unlike in patients with acute myeloid leukemia and normal karyotypes, FLT3 activation mutations were found to have no prognostic significance for patients with APL.

  6. Original Article

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Disease Site

      Lung Disease
      You have free access to this content
      Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma : A possible diagnostic tool for lymph node metastasis (pages 1217–1222)

      Masaya Tamura and Yasuhiko Ohta

      Version of Record online: 31 JUL 2003 | DOI: 10.1002/cncr.11529

      • original image
      • original image
      • original image
      • original image

      Circulating vascular endothelial growth factor-C (VEGF-C) may provide additional information for distinguishing between the absence and presence of lymph node metastasis in patients with lung carcinoma. A combination assay of circulating VEGF-C with vascular endothelial growth factor revealed a high specificity for diagnosing lymph node metastasis.

  7. Original Articles

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Disease Site

      Melanoma
      You have free access to this content
      Prognosis for patients with thin cutaneous melanoma : Long-term survival data from the New South Wales Central Cancer Registry and the Sydney Melanoma Unit (pages 1223–1231)

      J. Gregory McKinnon, Xue Qin Yu, William H. McCarthy and John F. Thompson

      Version of Record online: 20 AUG 2003 | DOI: 10.1002/cncr.11624

      • original image
      • original image
      • original image
      • original image
      • original image

      Survival data for patients with thin (≤ 1 mm) primary cutaneous melanomas from the New South Wales Central Cancer Registry and the Sydney Melanoma Unit were reviewed. Melanoma-specific survival rates at 10 years were 96.4% and 92.7%, respectively.

  8. Original Article

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Disease Site

      Neuro-Oncology
      You have free access to this content
      Choroid metastases: Clinical features and treatments in 123 patients (pages 1232–1238)

      Isabelle d'Abbadie, Rodrigo Arriagada, Marc Spielmann and Monique G. Lê

      Version of Record online: 31 JUL 2003 | DOI: 10.1002/cncr.11622

      • original image

      In the current study, the authors analyzed the effects of radiotherapy and chemotherapy on visual improvement in 123 patients with choroid metastases (CM) using the Cox proportional hazards model. Sequential vinca alkaloid-based chemoradiotherapy was found to be significantly associated with a lower risk of treatment failure compared with radiotherapy alone.

  9. Original Articles

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Disease Site

      Neuro-Oncology
      You have free access to this content
      High incidence of thromboembolism in patients with central nervous system lymphoma (pages 1239–1242)

      Neta Goldschmidt, Eduard Linetsky, Edna Shalom, David Varon and Tali Siegal

      Version of Record online: 25 JUL 2003 | DOI: 10.1002/cncr.11623

      In a retrospective analysis of 42 patients with brain lymphoma, there was a high incidence (59.9%) of thromboembolic events. The authors recommend the use of prophylactic anticoagulation in newly diagnosed patients who are treated for brain lymphoma.

    2. You have free access to this content
      Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945 (pages 1243–1252)

      Maryam Fouladi, Daniel L. Hunt, Ian F. Pollack, Gregor Dueckers, Peter C. Burger, Laurence E. Becker, Allen J. Yates, Floyd H. Gilles, Richard L. Davis, James M. Boyett and Jonathan L. Finlay

      Version of Record online: 12 AUG 2003 | DOI: 10.1002/cncr.11637

      • original image
      • original image
      • original image
      • original image
      • original image

      This report calls attention to the importance of central pathologic review in large multiinstitutional trials of children with gliomas and suggests that aggressive front-line combined chemoradiotherapy does not confer a survival advantage in this highly selected population of patients.

    3. Discipline

      Epidemiology
      You have free access to this content
      The prevalence of patients with colorectal carcinoma under care in the U.S. (pages 1253–1261)

      Angela Mariotto, Joan L. Warren, Kevin B. Knopf and Eric J. Feuer

      Version of Record online: 12 AUG 2003 | DOI: 10.1002/cncr.11631

      • original image

      The authors estimated the proportion of elderly patients with colorectal carcinoma (CRC) in the U.S. who actually received care for their disease. CRC care prevalence measures by phase were extrapolated to the U.S. population age 65 years and older, and the resulting estimates provided a very detailed picture of the amount of care delivered in the U.S. population.

    4. Medical Oncology
      You have free access to this content
      Cancer rates among American Indians and Alaska Natives : Is there a national perspective? (pages 1262–1272)

      Judith Swan and Brenda K. Edwards

      Version of Record online: 20 AUG 2003 | DOI: 10.1002/cncr.11633

      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image

      National cancer surveillance systems can elucidate the differential burden of cancer among population groups, and information on cancer among American Indians and Alaska Natives (AIAN) is becoming more available as data systems are expanded and improved. Overall, cancer rates among AIAN populations were relatively stable over the years 1992–2000 compared with other population groups.

  10. Original Article

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Discipline

      Pathology
      You have free access to this content
      Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract (pages 1273–1282)

      Silvia Pizzi, Cinzia Azzoni, Daniela Bassi, Lorena Bottarelli, Massimo Milione and Cesare Bordi

      Version of Record online: 1 AUG 2003 | DOI: 10.1002/cncr.11621

      • original image

      Poorly differentiated endocrine carcinomas of the gastrointestinal tract exhibited high levels of chromosomal instability, including consistent inactivation of both the p53 and p16/Rb pathways and frequent loss of heterozygosity at 3p (possibly involving FHIT), the MEN1 locus, and 18q. Using comparative analysis, the genetic alteration pattern of poorly differentiated endocrine carcinomas was found to be more consistent with that of well-differentiated endocrine carcinomas than with that of nonendocrine colorectal adenocarcinomas.

  11. Original Articles

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Discipline

      Pediatric Oncology
      You have free access to this content
      Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol : The 30-year experience at Memorial Sloan-Kettering Cancer Center (pages 1283–1291)

      Jaume Mora, Daniel A. Filippa, Jing Qin and Norma Wollner

      Version of Record online: 25 JUL 2003 | DOI: 10.1002/cncr.11615

      • original image

      Until the 1970s, diffuse lymphoblastic lymphoma (DLBL) was considered to be incurable. However, with intensive multidrug regimens, the majority of patients can now be cured. In the current study, the authors present what to their knowledge is the longest follow-up presented to date (median, 20 years for survivors) of DLBL patients treated with a single protocol at a single institution.

  12. Original Article

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Discipline

      Pediatric Oncology
      You have free access to this content
      Extraocular retinoblastoma: A 13-year experience (pages 1292–1298)

      Célia Beatriz Gianotti Antoneli, Flávio Steinhorst, Karina de Cássia Braga Ribeiro, Paulo Eduardo R. S. Novaes, Martha M. M. Chojniak, Victor Arias and Beatriz de Camargo

      Version of Record online: 31 JUL 2003 | DOI: 10.1002/cncr.11647

      • original image
      • original image
      • original image

      In the current study, patients with extraocular retinoblastoma were reported to have a poor prognosis when treated with conventional modalities. The authors evaluated two different regimens of treatment according to the class of the disease and period of treatment. The introduction of combined chemotherapy with ifosfamide and etoposide did not appear to improve the prognosis.

  13. Original Articles

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. Discipline

      Psychological Oncology
      You have free access to this content
      Prognostic significance of psychosocial factors in African-American and white breast cancer patients : A population-based study (pages 1299–1308)

      Hosanna Soler-Vila, Stanislav V. Kasl and Beth A. Jones

      Version of Record online: 18 AUG 2003 | DOI: 10.1002/cncr.11670

      It has been suggested that psychosocial factors influence survival among cancer patients. The prognostic significance of selected psychosocial variables was investigated in a cohort of African-American women and white women who were diagnosed recently with breast cancer and were followed for approximately 10 years. Although results showed no prognostic significance for coping styles, health locus of control, or fatalism, perceived emotional support was associated with survival independent of a wide range of potential confounders.

    2. Radiation Oncology
      You have free access to this content
      The risk of multiple primary breast and thyroid carcinomas : Role of the radiation dose (pages 1309–1317)

      Élisabeth Adjadj, Carole Rubino, Akhtar Shamsaldim, Monique G. Lê, Martin Schlumberger and Florent de Vathaire

      Version of Record online: 25 JUL 2003 | DOI: 10.1002/cncr.11626

      The previously reported excess incidence of breast carcinoma after thyroid carcinoma was not related to radiation treatment with 131I and/or with external radiation therapy. Radiation therapy for breast carcinoma did not increase the risk of subsequent thyroid carcinoma.

    3. Translational Research
      You have free access to this content
      Combination of early bisphosphonate administration and irradiation leads to improved remineralization and restabilization of osteolytic bone metastases in an animal tumor model (pages 1318–1324)

      Robert Krempien, Peter E. Huber, Wolfgang Harms, Martina Treiber, Michael Wannenmacher and Burkhardt Krempien

      Version of Record online: 25 JUL 2003 | DOI: 10.1002/cncr.11646

      • original image
      • original image
      • original image

      The current study demonstrated that in an animal tumor model, bisphosphonate administration in combination with irradiation leads to improved remineralization and restabilization of osteolytic bone metastases. Early bisphosphonate treatment geared toward preservation of the structural integrity of bone facilitates a faster and more physiologic rebuilding of osteolytic bone lesions after radiotherapy.

  14. Correspondence

    1. Top of page
    2. Review Articles
    3. Original Article
    4. Original Articles
    5. Original Article
    6. Original Articles
    7. Original Article
    8. Original Articles
    9. Original Article
    10. Original Articles
    11. Original Article
    12. Original Articles
    13. Original Article
    14. Original Articles
    15. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Author reply (pages 1326–1327)

      Laurent Zelek

      Version of Record online: 20 AUG 2003 | DOI: 10.1002/cncr.11572

    3. You have free access to this content
      The biology of breast carcinoma (pages 1327–1328)

      Richard D. Kennedy, Jennifer E. Quinn, Paul B. Mullan and D. Paul Harkin

      Version of Record online: 26 JUN 2003 | DOI: 10.1002/cncr.11591

    4. You have free access to this content
      Author reply (pages 1328–1329)

      Judith Clancy Keen and Nancy E. Davidson

      Version of Record online: 26 JUN 2003 | DOI: 10.1002/cncr.11592

SEARCH

SEARCH BY CITATION